Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Court Rules on Pharmacy Ownership
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
In a landmark case, the European Court of Justice has upheld laws limiting ownership of pharmacies to pharmacists.
This is a significant blow to the proponents of deregulation and ownership of pharmacies by large retail chains, and the ruling will bolster arguments for retaining similar restrictions in Australia, where deregulation is to be reviewed in 2010.
The explanation of the court's decision, handed down in May 2009, is compellingly simple:
“Unlike pharmacists, non-pharmacists by definition lack training, experience and responsibility” and “do not provide the same safeguards as pharmacists."
This decision provides clarity and allows for better planning by European pharmacists.
The story was reported on the Bloomberg.com site.
"Europe’s largest drug wholesaler (Celesio), lost a bid to have a European court overturn rules in Germany and Italy that prevent it from owning pharmacies.
The European Court of Justice in Luxembourg said today it’s up to each of the EU’s 27 nations to “determine the level of protection of public health.” The EU’s highest court ruled Italian and German laws that allow only licensed pharmacists to own pharmacies are justified because they ensure drug distribution is reliable and of good quality. Celesio fell 15 percent in Frankfurt trading.
“This is bad for Celesio, but it’s not a catastrophe, they still have other good growth opportunities,” Karl-Heinz Scheunemann, an analyst at Landesbank Baden-Wuerttemberg in Stuttgart, Germany, said in an interview today. “We had hoped the decision could be a bit different.”
"The court’s ruling today could have opened Germany’s 37 billion-euro ($50 billion) pharmacy business to Celesio. At stake were similar bans in at least 10 other EU countries, including Austria, France and Spain."
“Unlike pharmacists, non-pharmacists by definition lack training, experience and responsibility” and “do not provide the same safeguards as pharmacists,” the court said today.Building up pharmacy chains in Germany and Italy “is far out of reach now,” Thomas Maul, an analyst at DZ Bank AG in Frankfurt, said in a note to clients today. “Pharmacy deregulation in Germany was an essential part of Celesio’s ‘equity story’ over the last years. The ‘equity story’ has vanished now.”
Celesio became involved in the EU case after it bought mail-order company DocMorris in 2007. DocMorris, in a 2006 suit by a German pharmacy trade group, was accused of violating a rule that restricts ownership of retail operations to licensed druggists when it opened a shop in the state of Saarland.
Celesio and DocMorris will now focus on expanding the brand partner and mail-order businesses, Oesterle said."
For the full story visit http://www.bloomberg.com/apps/news?pid=20601092&sid=aQzjC7i6b89k&refer=italy
Research Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment